Last reviewed · How we verify
NCT01410409: MEDIC
Structured Treatment of Osteoarthritis of the Knee With or Without Total Knee Replacement. A Randomized Controlled Trial of Pain, Physical Function and Quality of Life With 12months Follow-up
NA trial testing Neuromuscular training (NEMEX-TJR) in Osteoarthritis of the Knee in 100 participants. Completed in 1 March 2015.
1 March 2015
Quick facts
| Lead sponsor | Northern Orthopaedic Division, Denmark |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 September 2011 |
| Primary completion | 1 March 2015 |
| Estimated completion | 1 March 2015 |
| Sites | 3 locations across Denmark |
Drugs / interventions tested
- Neuromuscular training (NEMEX-TJR)
- Paracetamol (Paracetamol) — full drug profile →
- Burana — full drug profile →
- Pantoprazol — full drug profile →
- Dietary counseling
- Patient education — full drug profile →
- TKR
- Insoles
Conditions studied
- Osteoarthritis of the Knee — all drugs for Osteoarthritis of the Knee →
Sponsor
Northern Orthopaedic Division, Denmark — full company profile →
Who can join
Eligibility, any sex, with Osteoarthritis of the Knee. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Change in KOOS4 From Baseline (Knee Injury and Osteoarthritis Outcome Score)
Time frame: Primary: 12months.
The average score for four of the five KOOS subscales, covering pain, symptoms, difficulties in functions of daily living, and quality of life (KOOS4), with scores ranging from 0 (worst) to 100 (best). Between group comparisons of treatment effect (change in KOOS4 from baseline to 1 year follow-up) will be dependent on data distribution. Between group comparisons of treatment effect (change in KOO
Sponsor's own description
The purpose of this study is to test whether surgical insertion of total knee replacement provides further improvement in quality of life, pain and function in addition to an algorithm for systematic non-surgical treatment consisting of corrective insoles, neuromuscular training, weight loss, patient education and pharmacological treatment with paracetamol, NSAIDs and Pantoprazol in patients with knee OA, collectively called the MEDIC-treatment(Medicine Exercise Diet Insoles Cognitive). The H1-hypothesis is that surgery with insertion of TKR in addition to the MEDIC-treatment results in a greater increase in quality of life and functional capacity and greater reduction in pain than the MEDIC- treatment alone at the primary endpoint, which is follow-up 12months after the start of the treatment. See statistical analysis plan available under "Links" for further description of the study.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
A Randomized, Controlled Trial of Total Knee Replacement.
Skou ST, Roos EM, Laursen MB, Rathleff MS, et al · · 2015 · cited 504× · PMID 26488691 · DOI 10.1056/nejmoa1505467 -
Total knee replacement and non-surgical treatment of knee osteoarthritis: 2-year outcome from two parallel randomized controlled trials.
Skou ST, Roos EM, Laursen MB, Rathleff MS, et al · · 2018 · cited 123× · PMID 29723634 · DOI 10.1016/j.joca.2018.04.014 -
Cost-effectiveness of total knee replacement in addition to non-surgical treatment: a 2-year outcome from a randomised trial in secondary care in Denmark.
Skou ST, Roos E, Laursen M, Arendt-Nielsen L, et al · · 2020 · cited 19× · PMID 31948990 · DOI 10.1136/bmjopen-2019-033495 -
Total knee replacement plus physical and medical therapy or treatment with physical and medical therapy alone: a randomised controlled trial in patients with knee osteoarthritis (the MEDIC-study).
Skou ST, Roos EM, Laursen MB, Rathleff MS, et al · · 2012 · cited 16× · PMID 22571284 · DOI 10.1186/1471-2474-13-67 -
Knee Confidence as It Relates to Self-reported and Objective Correlates of Knee Osteoarthritis: A Cross-sectional Study of 220 Patients.
Skou ST, Rasmussen S, Simonsen O, Roos EM. · · 2015 · cited 12× · PMID 26304646 · DOI 10.2519/jospt.2015.5864
Verify or expand the search:
- PubMed search for NCT01410409
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteoarthritis of the Knee
Currently open trials in the same condition.
- NCT07302204 — Efficacy of Aerobic Exercise Versus Therapeutic Exercises on Exercise-induced Hypoalgesia in Knee Osteoarthritis · NA · recruiting
- NCT06549686 — A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee · Phase 3 · recruiting
- NCT05985785 — Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection · NA · recruiting
- NCT05035810 — A Pragmatic Trial to Determine the Benefit of Behaviorally Enhanced Exercise Incentives and Corticosteroid Injections in · Phase 3 · active not recruiting
- NCT04992624 — Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee · Phase 2 · recruiting
Other Northern Orthopaedic Division, Denmark trials
Trials by the same sponsor.
- NCT07202390 — Intraarticular Gold Microparticles for Knee Osteoarthritis · NA · not yet recruiting
- NCT05284253 — Is There an Allergy to Pure Metallic Gold Microparticles? · NA · unknown
- NCT06186115 — Intraarticular Gold Microparticles for Hip Osteoarthritis · unknown
- NCT04332055 — RCT Measuring the Effect of the ERVIN Software · NA · completed
- NCT02405104 — Chlorzoxazone in Hip and Knee Arthroplasty · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01410409 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northern Orthopaedic Division, Denmark
- Last refreshed: 14 September 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01410409.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing